Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7241-98-7
2. Dihydroaflatoxin G1
3. 2ms0d8wa29
4. (7ar-cis)-3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione
5. Aflatoxin G2 0.5 Microg/ml In Acetonitrile
6. 1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-methoxy-, (7ar,10as)-
7. Aflatoxing2
8. Unii-2ms0d8wa29
9. Ccris 4936
10. Hsdb 3456
11. 1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-methoxy-, (7ar,10as)-
12. Einecs 230-643-4
13. Aflatoxin G2 [mi]
14. Aflatoxin G2 [hsdb]
15. Aflatoxin G2 In Acetonitrile
16. Chebi:80705
17. Aflatoxin G2, Reference Material
18. Dtxsid80891796
19. Ex-a4123
20. Hy-n6698
21. Zinc2029390
22. Mfcd00078141
23. 1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione,3,4,7aalpha,9,10,10aalpha-hexahydro-5-methoxy-
24. 1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-
25. 3,4,7aalpha,9,10,10aalpha-hexahydro-5-methoxy-1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)-benzopyran-1,12-dione
26. Cs-0099736
27. C16754
28. Q26841280
29. Aflatoxin G2, From Aspergillus Flavus, >=98.0% (hplc/tlc)
30. Aflatoxin G2 Solution, 0.5 Mug/ml In Acetonitrile, Analytical Standard
31. Aflatoxin G2 Solution, 3.80 Mug/g In Acetonitrile, Erm(r) Certified Reference Material
32. (3s,7r)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,9,11,13(18)-tetraene-17,19-dione
33. (7ar,cis)3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h- Furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)chromene-1,12-dione
34. (7ar,cis)3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)chromene-1,12-dione
35. 1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran- 1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-methoxy-, (7ar,10as)-
36. 1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione, 3,4,7a-alpha,9,10,10a-alpha-hexahydro-5-methoxy-
37. Aflatoxin G2 Solution, Certified Reference Material, 3 Mug/ml In Benzene:acetonitrile (98:2), Ampule Of 1 Ml
| Molecular Weight | 330.29 g/mol |
|---|---|
| Molecular Formula | C17H14O7 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 330.07395278 g/mol |
| Monoisotopic Mass | 330.07395278 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
To evaluate the rate at which the four main aflatoxins (aflatoxins B1, B2, G1 and G2) are able to cross the luminal membrane of the rat small intestine, a study about intestinal absorption kinetics of these mycotoxins has been made. In situ results obtained showed that the absorption of aflatoxins in rat small intestine is a very fast process that follows first-order kinetics, with an absorption rate constant (ka) of 5.84 +/- 0.05 (aflatoxin B1), 4.06 +/- 0.09 (aflatoxin B2), 2.09 +/- 0.03 (aflatoxin G1) and 1.58 +/- 0.04 (aflatoxin G2) h-1, respectively.
Ramos A et al; Mycopathologia 134(1): p.27-30 (1996)
Aflatoxin G2 ... /is/ the 9,10-dihydro derivative of aflatoxin G1.
O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 35
With the 4 principal Aflatoxins tested, the order of inhibitory effect on RNA polymerase II was: B1 greater than G1 greater than B1, G2.
Yu FL et al; Carcinogenesis (London) 3 (9): 1005 (1982)
Phagocytosis, intracellular killing of Candida albicans, and superoxide production by rat peritoneal macrophages exposed to aflatoxins B1, B2, G1, G2, B2a, and M1 at several times and concentration were analyzed to evaluate the intensity of a depressive effect for each mycotoxin. All aflatoxins used at very low concn had a depressive effect on the functions of macrophages. The biggest impairment of phagocytosis, intracellular killing, and spontaneous superoxide production was observed in macrophages exposed to aflatoxins B1 and M1.
PMID:2176448 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC184993 Cusumano V et al; Appl Environ Microbiol 56 (11): 3482-4 (1990)
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
25
PharmaCompass offers a list of Aflatoxin G2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aflatoxin G2 manufacturer or Aflatoxin G2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aflatoxin G2 manufacturer or Aflatoxin G2 supplier.
PharmaCompass also assists you with knowing the Aflatoxin G2 API Price utilized in the formulation of products. Aflatoxin G2 API Price is not always fixed or binding as the Aflatoxin G2 Price is obtained through a variety of data sources. The Aflatoxin G2 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aflatoxin G2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aflatoxin G2, including repackagers and relabelers. The FDA regulates Aflatoxin G2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aflatoxin G2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aflatoxin G2 supplier is an individual or a company that provides Aflatoxin G2 active pharmaceutical ingredient (API) or Aflatoxin G2 finished formulations upon request. The Aflatoxin G2 suppliers may include Aflatoxin G2 API manufacturers, exporters, distributors and traders.
Aflatoxin G2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aflatoxin G2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aflatoxin G2 GMP manufacturer or Aflatoxin G2 GMP API supplier for your needs.
A Aflatoxin G2 CoA (Certificate of Analysis) is a formal document that attests to Aflatoxin G2's compliance with Aflatoxin G2 specifications and serves as a tool for batch-level quality control.
Aflatoxin G2 CoA mostly includes findings from lab analyses of a specific batch. For each Aflatoxin G2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aflatoxin G2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Aflatoxin G2 EP), Aflatoxin G2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aflatoxin G2 USP).
